Dapsone Induced Methemoglobinemia in Pediatric Patient: A Case Report
DOI:
https://doi.org/10.19166/med.v15i1.10767Keywords:
Methemoglobinemia, DapsoneAbstract
Background: Acquired methemoglobinemia is significantly more common than the congenital form, though it remains a rare condition. Most cases arise from accidental chemical exposure or the use of topical and local anesthetics.
Case Description: We present a case of 14-year-old male presented with complaints of dark grayish discoloration of the skin on the face and hands, persisting for the past two months prior to admission. He was later diagnosed with dapsone induced methemoglobinemia. Patient was then discharged with oral therapy consisting of agents with antioxidant properties and instructed to discontinue dapsone consumption.
Conclusions: In pediatric patients undergoing dapsone therapy, the risk of dapsone induced methemoglobinemia should be carefully considered to ensure early identification and prompt management, thus minimizing the potential for severe complications.
References
1. Ludlow JT, Wilkerson RG, Nappe TM. Methemoglobinemia. PubMed. Treasure Island (FL): StatPearls Publishing; 2020. Available from: https://www.ncbi.nlm.nih.gov/books/NBK537317/
2. Mudan A. Methemoglobinemia. In: Olson KR, Smollin CG, Anderson IB, Benowitz NL, Blanc PD, Kim-Katz SY, et al., editors. Poisoning & Drug Overdose. 8th ed. New York: McGraw Hill; 2022. Available from: https://accessmedicine.mhmedical.com/content.aspx?bookid=3195§ionid=266329732
3. Prchal JT. Methemoglobinemia and Other Dyshemoglobinemias. In: Kaushansky K, Prchal JT, Burns LJ, Lichtman MA, Levi M, Linch DC, editors. Williams Hematology, 10e. New York, NY: McGraw-Hill Education; 2021. Available from: https://hemonc.mhmedical.com/content.aspx?bookid=3159§ionid=265060101
4. Ganesan S, Sahu R, Walker LA, Tekwani BL. Cytochrome P450‐dependent toxicity of dapsone in human erythrocytes. Journal of Applied Toxicology. 2010 Apr 1;30(3):271–5. https://doi.org/10.1002/jat.1493
5. Akhtar J, Johnston BD, Krenzelok EP. Mind the Gap. The Journal of Emergency Medicine. 2007 Aug;33(2):131–2. https://doi.org/10.1016/j.jemermed.2006.11.016
6. Goh CL, Pan JY. Dapsone. In: Kang S, Amagai M, Bruckner AL, Enk AH, Margolis DJ, McMichael AJ, et al., editors. Fitzpatrick’s Dermatology, 9e. New York, NY: McGraw-Hill Education; 2019. Available from: https://accessmedicine.mhmedical.com/content.aspx?bookid=2570§ionid=210413309
7. Papadakis MA, McPhee SJ. Methemoglobinemia. In: Quick Medical Diagnosis & Treatment 2024. New York, NY: McGraw-Hill Education; 2024. Available from: https://accessmedicine.mhmedical.com/content.aspx?aid=1204250629
8. Smollin C. Methemoglobinemia-Inducing Agents Poisoning. In: Papadakis MA, Rabow MW, McQuaid KR, Gandhi M, editors. Current Medical Diagnosis & Treatment 2025. New York, NY: McGraw-Hill Education; 2025. Available from: https://accessmedicine.mhmedical.com/content.aspx?aid=1209246970
9. Lolascon A, Bianchi P, Andolfo I, et al. Recommendations for Diagnosis and Treatment of Methemoglobinemia. American Journal of Hematology. 2021; 96(12):1666–1678. https://doi.org/10.1002/ajh.26340
10. Clarke G, Mao J, Fan Y, et al. N-Acetylcysteine: A Novel Approach to Methaemoglobinaemia in Normothermic Liver Machine Perfusion. Scientific Reports. 2023;13(1):19022. https://doi.org/10.1038/s41598-023-45206-z
11. Hemapriya J, Sehgal T, Kumar Datta S, Arulselvi S. Drug-induced methemoglobinemia. QJM: An International Journal of Medicine. 2022 Sep 1;115(9):619–20. https://doi.org/10.1093/qjmed/hcac157
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Brian Addyanto, Leni Lukman
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
Authors who publish with this journal agree to the following terms:
1) Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License (CC-BY-SA 4.0) that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
2) Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
3) Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website). The final published PDF should be used and bibliographic details that credit the publication in this journal should be included.
